Loading...
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
Improving the standard of clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small molecule antivirals like remdesivir (RDV) and biologics such as human monoclonal antibodies (mAb) have demonstrated therapeutic efficacy against SARS-CoV-2, the causative agen...
Na minha lista:
| Udgivet i: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cold Spring Harbor Laboratory
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7852229/ https://ncbi.nlm.nih.gov/pubmed/33532765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.01.27.428478 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|